JPS55147227A - Preparrtion of attenuated live mumps vaccine - Google Patents
Preparrtion of attenuated live mumps vaccineInfo
- Publication number
- JPS55147227A JPS55147227A JP5509479A JP5509479A JPS55147227A JP S55147227 A JPS55147227 A JP S55147227A JP 5509479 A JP5509479 A JP 5509479A JP 5509479 A JP5509479 A JP 5509479A JP S55147227 A JPS55147227 A JP S55147227A
- Authority
- JP
- Japan
- Prior art keywords
- virus
- mumps
- cell
- attenuated live
- strong
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/165—Mumps or measles virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
- C12N2760/18734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5509479A JPS55147227A (en) | 1979-05-04 | 1979-05-04 | Preparrtion of attenuated live mumps vaccine |
US06/100,957 US4324861A (en) | 1979-05-04 | 1979-12-06 | Preparation of live attenuated mumps virus for a vaccine |
BE2/58270A BE880616A (fr) | 1979-05-04 | 1979-12-14 | Preparation de vaccin vivant attenue du virus des oeillons |
FR7932098A FR2455628A1 (fr) | 1979-05-04 | 1979-12-31 | Procede de preparation d'un virus vaccinal vivant attenue contre les oreillons |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5509479A JPS55147227A (en) | 1979-05-04 | 1979-05-04 | Preparrtion of attenuated live mumps vaccine |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS55147227A true JPS55147227A (en) | 1980-11-17 |
JPS575205B2 JPS575205B2 (ja) | 1982-01-29 |
Family
ID=12989142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5509479A Granted JPS55147227A (en) | 1979-05-04 | 1979-05-04 | Preparrtion of attenuated live mumps vaccine |
Country Status (4)
Country | Link |
---|---|
US (1) | US4324861A (ja) |
JP (1) | JPS55147227A (ja) |
BE (1) | BE880616A (ja) |
FR (1) | FR2455628A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62126137A (ja) * | 1985-11-26 | 1987-06-08 | シユウアイツエリツシエス・ゼル−ム−ウント・イムプフインステイトウト・ウント・インステイトウト・ツ−ル・エルフオルシユング・デル・インフエクツイオンスクランクハイテン | 流行性耳下腺炎に対する生ワクチン |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57173702U (ja) * | 1981-04-30 | 1982-11-02 | ||
ES2000034A6 (es) * | 1985-11-26 | 1987-10-01 | Schweiz Serum & Impfinst | Procedimiento para la preparacion de una vacuna viva contra paperas |
US5024836A (en) * | 1987-05-04 | 1991-06-18 | Merck & Co., Inc. | Stable lyophilized live herpes virus vaccine |
WO1991002053A1 (en) * | 1989-08-01 | 1991-02-21 | Arthur Webster Pty. Ltd. | Low virulence laryngotracheitis (ilt) virus for vaccinating birds |
US5360736A (en) * | 1992-06-04 | 1994-11-01 | Merck & Co., Inc. | Process for attenuated varicella zoster virus vaccine production |
WO1993024616A1 (en) * | 1992-06-04 | 1993-12-09 | Merck & Co., Inc. | Process for attenuated varicella zoster virus vaccine production |
US5728386A (en) * | 1993-12-21 | 1998-03-17 | Merck & Co., Inc. | Thermostable varicella zoster virus |
HRP950097A2 (en) * | 1994-03-08 | 1997-06-30 | Merck & Co Inc | Hepatitis a virus culture process |
US20080294361A1 (en) * | 2007-05-24 | 2008-11-27 | Popp Shane M | Intelligent execution system for the monitoring and execution of vaccine manufacturing |
WO2010144797A2 (en) | 2009-06-12 | 2010-12-16 | Vaccine Technologies, Incorporated | Influenza vaccines with enhanced immunogenicity and uses thereof |
CN103756976A (zh) * | 2014-01-08 | 2014-04-30 | 北京民海生物科技有限公司 | F基因型腮腺炎病毒株mhm-19的二倍体细胞适应方法 |
CN108949672A (zh) * | 2018-08-02 | 2018-12-07 | 重庆市畜牧科学院 | 鹅成纤维细胞培养基及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3555149A (en) * | 1968-07-05 | 1971-01-12 | Merck & Co Inc | Mumps vaccine and its preparation |
US4071618A (en) * | 1974-09-03 | 1978-01-31 | Research Foundation For Microbial Diseases Of Osaka University | Process for preparing virus disease live vaccines |
US3961046A (en) * | 1974-12-02 | 1976-06-01 | American Cyanamid Company | Mumps vaccine and preparation thereof |
-
1979
- 1979-05-04 JP JP5509479A patent/JPS55147227A/ja active Granted
- 1979-12-06 US US06/100,957 patent/US4324861A/en not_active Expired - Lifetime
- 1979-12-14 BE BE2/58270A patent/BE880616A/fr not_active IP Right Cessation
- 1979-12-31 FR FR7932098A patent/FR2455628A1/fr active Granted
Non-Patent Citations (2)
Title |
---|
THE KITASATO AND ARCHIVES OF EXPERIMENTAL MEDINE=1976 * |
THE KITASATO ARCHIVES OF EXPERIMENTAL MEDICINE=1976 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62126137A (ja) * | 1985-11-26 | 1987-06-08 | シユウアイツエリツシエス・ゼル−ム−ウント・イムプフインステイトウト・ウント・インステイトウト・ツ−ル・エルフオルシユング・デル・インフエクツイオンスクランクハイテン | 流行性耳下腺炎に対する生ワクチン |
JPH0470288B2 (ja) * | 1985-11-26 | 1992-11-10 | Shubaitsu Serumu Unto Infu Inst Unto Inst Tsuuru Erufuorushungu Deru Infuekuchionsukurankuhaiten |
Also Published As
Publication number | Publication date |
---|---|
FR2455628B1 (ja) | 1985-01-11 |
JPS575205B2 (ja) | 1982-01-29 |
BE880616A (fr) | 1980-04-01 |
FR2455628A1 (fr) | 1980-11-28 |
US4324861A (en) | 1982-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS55147227A (en) | Preparrtion of attenuated live mumps vaccine | |
Khodakevich et al. | Monkeypox virus: ecology and public health significance | |
Rupert | Enzymatic photoreactivation: overview | |
KR0156732B1 (ko) | 연속 셀 라인에서의 ibdv 생성 | |
ES2038689T3 (es) | Procedimiento de cultivo del virus de la rinotraqueitis infecciosa de la pava, y vacuna preparada a partir del virus asi obtenido. | |
US4301148A (en) | Anticocoidial drug | |
CA1113860A (en) | Live newcastle disease virus vaccine | |
JPS5527178A (en) | Live influenza virus vaccine | |
ES373631A1 (es) | Procedimiento para la obtencion de una vacuna activa contrala enfermedad de maret. | |
DE69824856D1 (de) | Rückgewinnung von viren aus zellkulturen durch verwendung einer hypertonischen salzlösung | |
NL7800708A (nl) | Nieuw rabies vaccin. | |
KR20000069501A (ko) | 뉴우캐슬병에 대한 난내 백신화 | |
Vernon et al. | Effect of tetraploidy on learning and retention in the salamander | |
Loebenstein | Native protein, an immunizing agent against virus infection | |
US3331736A (en) | Modified laryngotracheitis vaccine | |
Wood et al. | Cultivation of Poliomyelitis Virus in Tissue Culture III. Synthetic Medium in Roller Tube Cultures. | |
AU6258480A (en) | Prep" of influenza virus strains and vaccines | |
Mack et al. | Serological response in chickens to beta-propiolactone treated Newcastle disease virus | |
Chung et al. | Studies on poxvirus isolated from a magpie in Queensland | |
EP0156478A3 (en) | Propagation of group ii avian adeno (aa) virus in avian cell culture and vaccine produced | |
Gardner et al. | Recombination as a mechanism in the evolution of influenza viruses: a two-year study of ducks in Hong Kong | |
YU46029B (sh) | Postopek za pripravo živega cepiva proti mumpsu | |
Bowman et al. | Effect of controlled lighting on production characters in the fowl | |
JPS57167925A (en) | Preparation of mixed vaccine for domestic fowl | |
JPH0413997B2 (ja) |